During the past decade, WakeMed Heart and Vascular conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "WakeMed Heart and Vascular" are "Abdominal Surgery" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Surgery" (1 trials), "Chronic Kidney Disease" (1 trials) and "Femoral Artery Occlusion" (1 trials). Many other conditions were trialed in "WakeMed Heart and Vascular" in a lesser frequency.

Most popular intervention types in "WakeMed Heart and Vascular" are "Device" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DyeVert Plus Contrast Reduction System" (1 trials), "Lutonix Drug Coated Balloon" (1 trials), "Moxy Drug Coated Balloon" (1 trials), "Prevena Plus Incision Management System with Prevena Dressings" (1 trials) and "Pulse Field Ablation" (1 trials). Other intervention names were less common.

The vast majority of trials in "WakeMed Heart and Vascular" are 6 trials for "All" genders.

Currently, there are NaN active trials in "WakeMed Heart and Vascular". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in WakeMed Heart and Vascular, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in WakeMed Heart and Vascular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".